Using genetically modified extracellular vesicles as a non-invasive strategy to evaluate brain-specific cargo

David Rufino-Ramos1, Sevda Lule2, Shadi Mahjoum2

  • 1Neurology and Radiology Department, Massachusetts General Hospital, Harvard Medical School, 13(th)Street, Building 149, Charlestown, MA, 02129, USA; CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Rua Larga, Coimbra, 3004-504, Portugal; Faculty of Pharmacy, University of Coimbra, Coimbra, 3000-548, Portugal; CIBB-Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.

Biomaterials
|January 16, 2022
PubMed
Summary

Researchers developed a novel platform to isolate and track brain-derived extracellular vesicles (EVs) in blood. This breakthrough enables monitoring of brain cell status through easily accessible biofluids, advancing neuroscience research.

Related Concept Videos